NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that Gary Sender has joined the company as Executive Vice President and Chief Financial Officer. Mr. Sender will be responsible for leading Synergy’s financial strategy and operations, supporting all functions of the organization.
Help employers find you! Check out all the jobs and post your resume.
